Metropolitan Bank Reports Strong Q4 2025 Earnings, Raises Dividend by 33%
MCB sits 69% above its 52-week low of $47.08.
Summary
Metropolitan Bank Holding Corp. reported strong Q4 2025 financial results, including a significant increase in diluted EPS and net interest margin, alongside a 33% dividend hike.
Key Events · Earnings and Guidance · MCB
-
Strong Q4 2025 Financial Performance
Diluted earnings per share (EPS) surged to $2.77, a substantial increase from $0.67 in Q3 2025 and $1.88 in Q4 2024. Net income reached $28.9 million for the quarter.
-
Net Interest Margin Expansion
Net interest margin (NIM) improved to 4.10% in Q4 2025, up from 3.88% in the prior linked quarter and 3.66% in the prior year period, driven by rigorous loan and deposit pricing initiatives.
-
Quarterly Dividend Increase
The company declared a quarterly cash dividend of $0.20 per share on its common stock, representing a 33% increase from the prior quarterly dividend of $0.15 per share.
-
Asset Quality Deterioration
The ratio of non-performing loans to total loans increased to 1.28% at December 31, 2025, up from 0.54% at December 31, 2024, primarily due to a single out-of-market commercial real estate multi-family loan relationship.
Analysis · MCB · Finance
Metropolitan Bank Holding Corp. delivered robust fourth-quarter results, significantly exceeding prior quarter and prior year earnings per share. The bank demonstrated strong operational performance with notable net interest margin expansion and healthy loan and deposit growth. The decision to increase the quarterly cash dividend by 33% signals management's confidence in future profitability and capital strength. While the increase in non-performing loans is a watch item, attributed primarily to a single commercial real estate multi-family loan, the overall financial health and capital ratios remain strong, positioning the bank for continued growth.
At the time of this filing, MCB was trading at $79.63 on NYSE in the Finance sector, with a market capitalization of approximately $820M. The 52-week trading range was $47.08 to $83.48. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.